Concord Biotech IPO Date, Price, GMP, Review, Details

The Concord Biotech IPO has begun on 04-Aug-2023. It will close on 08-Aug-2023. The Total IPO Size is 1,551.00 Crore . The company set its IPO price is 741 Rs Per Share. Basically, there are three basic categories in Concord Biotech IPO Subscription 1) Qualified Institutional Buyers 2) Non-Institutional Investors 3) Retail.

Concord Biotech is established in 1984.

Concord Biotech is an biopharma company based on India.

They are one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2021.

They supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.

Concord Biotech IPO Promotor Shareholding

Name of the Promoter No. of Shares held Percentage of total Shareholding Average cost of Acquisition
Sudhir Vaid 30,169,524 28.84% 3.83
Ankur Vaid 586,520 0.56% 2.27
Total 30,756,044 29.40%

Concord Biotech IPO Date, Details & Price Band

The Concord Biotech IPO Price Band, IPO Dates, Market lot and other details mention in be below table.

IPO Opening Dates 04-Aug-2023
IPO Closing Dates 08-Aug-2023
Price Band 705-741 Rs
Fresh issue NIL
OFS issue 1,551.00 Crore
Total IPO size 1,551.00 Crore
Minimum bid (lot size) 20 Shares
Face Value 1 INR Per Share
Issue Type Book Built Issue IPO
Listing On NSE, BSE

Concord Biotech IPO Reservation

There are three basic category of Concord Biotech IPO Reservation, other mention in be below table.

QIB Allocation 50%
HNI Allocation 15%
Retail Allocation 35%

Concord Biotech IPO Market Lot

The Concord Biotech IPO minimum market lot is 1 shares With 20 ₹ Amount per application.

Lot No of Shares Amount
Retail Minimum 1 20 14,820 ₹
Retail Maximum 13 260 1,92,660 ₹
S-HNI Minimum 14 280 2,07,480 ₹
S-HNI Maximum 67 1,340 9,92,940 ₹
B-HNI Maximum 68 1,360 10,07,760 ₹

Restated Consolidated Financial Record of the three year (Amt. in Crore)

Total Assets Total Revenue Profit After Tax
31-Mar-21 1,182.55 630.75 234.89
31-Mar-22 1,312.80 736.35 174.93
31-Mar-23 1,513.98 888.48 240.08
EPS (₹) NAV (₹) RONW(%) Borrowings (Crores)
31-Mar-21 22.45 95.53 26.55 86.35
31-Mar-22 16.72 105.45 16.64 60.59
31-Mar-23 22.95 123.31 20.06 31.24

Concord Biotech IPO GMP & Grey Market Premium

Concord Biotech IPO GMP Grey market premium has been started today. Check Latest Concord Biotech IPO GMP, Kostak Rates and Subject to Sauda Price here.

Concord Biotech IPO Prospectus

Concord Biotech IPO Prospectus Available on BSE and Sebi Website as well as on our Portal. Please click here to Download Concord Biotech IPO Prospectus.

Concord Biotech IPO Prospectus Download
DRHP Download
RHP Download

Concord Biotech IPO Reviews

Angel Broking – Update Soon
Choice Broking – Update Soon
Prabhudas Lilladher – Update Soon

Concord Biotech IPO Form Download

Concord Biotech IPO form Available on NSE, BSE Website as well as on our Portal. Please click here to Download Concord Biotech IPO forms.

Concord Biotech IPO Allotment Date & Details

Allotment Date 11-August-2023
Initiation of refunds 14-August-2023
Transfer of shares to Demat accounts 16-August-2023
Listing Date 17-August-2023
Check Allotment Status Click here

Registrar of Concord Biotech

Link Intime India Private Limited
C 101, 247 Park
L.B.S Marg
Vikhroli (West), Mumbai 400 083
Maharashtra, India
Tel: +91 810 811 4949
[email protected]
Investor Grievance ID:
[email protected]
Contact Person: Shanti Gopalkrishnan
SEBI Registration Number:

Concord Biotech Contact Details

Concord Biotech Limited
Trasad Road Dholka,
Ahmedabad – 382225
Phone: 079-6813 8700
Email: [email protected]

Concord Biotech IPO Lead Managers

Jefferies India Private Limited
Level 16, Express Towers
Nariman Point, Mumbai 400021
Maharashtra, India
Tel: +91 22 4356 6000
E-mail: [email protected]
Investor Grievance ID:
[email protected]
Contact Person: Suhani Bhareja
SEBI Registration Number: INM000011443

Citigroup Global Markets India Private Limited
1202, 12th Floor, First International Financial Centre,
G Block Bandra Kurla Complex, Bandra (East),
Mumbai 400098
Maharashtra, India
Tel: +91 22 6175 9999
E-mail: [email protected]
Investor Grievance ID: [email protected]
Contact Person: Karan Singh Hundal
SEBI Registration Number: INM000010718

Kotak Mahindra Capital Company Limited
1st Floor, 27 BKC, Plot No. 27
G Block, Bandra Kurla Complex
Bandra (East), Mumbai 400 051
Maharashtra, India
Tel: +91 22 4336 0000
E-mail: [email protected]
Investor Grievance ID: [email protected]
Contact Person: Ganesh Rane
SEBI Registration Number: INM000008704

Leave a Reply